Recent developments in Duchenne muscular dystrophy: facts and numbers.

about

Recent developments in Duchenne muscular dystrophy: facts and numbers.

Item

http://www.wikidata.org/entity/Q45174751

description

2017 nî lūn-bûn

@nan

2017 թվականի հոկտեմբերին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

name

Recent developments in Duchenne muscular dystrophy: facts and numbers.

@en

Recent developments in Duchenne muscular dystrophy: facts and numbers.

@nl

type

Item

label

Recent developments in Duchenne muscular dystrophy: facts and numbers.

@en

Recent developments in Duchenne muscular dystrophy: facts and numbers.

@nl

prefLabel

Recent developments in Duchenne muscular dystrophy: facts and numbers.

@en

Recent developments in Duchenne muscular dystrophy: facts and numbers.

@nl

P1476

Recent developments in Duchenne muscular dystrophy: facts and numbers.

@en

P2093

Maggie C Walter

http://www.w3.org/2001/XMLSchema#string

Peter Reilich

http://www.w3.org/2001/XMLSchema#string

P2860

Dystrophin-deficient large animal models: translational research and exon skipping

Therapy of Genetic Disorders-Novel Therapies for Duchenne Muscular Dystrophy.

Safety, tolerability, and pharmacokinetics of PTC124, a nonaminoglycoside nonsense mutation suppressor, following single- and multiple-dose administration to healthy male and female adult volunteers.

PTC124 targets genetic disorders caused by nonsense mutations.

A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy.

Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations.

Comparative cost of illness analysis and assessment of health care burden of Duchenne and Becker muscular dystrophies in Germany

The TREAT-NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations.

Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy.

Novel approaches to corticosteroid treatment in Duchenne muscular dystrophy

P304

681-685

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1002/JCSM.12245

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29076660

http://www.w3.org/2001/XMLSchema#string

P932

5659056

http://www.w3.org/2001/XMLSchema#string